HJB - Your Trusted Biologics CDMO Partner
HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB
HJB congratulates its partner BioneCure for receiving IND approval for BIO-106.
HJB congratulates its client on an approval of CMC process change supplemental application filed to NMPA in support of a late phase clinical trial in China.
HJB Congratulates its partner Kanova Biopharma for receiving IND approval from U.S.FDA for XKH001, a humanized monoclonal antibody for the treatment of autoimmune disease.
HJB congratulates its partner for receiving IND approval from NMPA.
HJB Congratulates its partner Miracogen for receiving IND acceptance from NMPA for MRG004A, an tissue factor-targeted antibody–drug conjugate.
HJB has installed, commissioned, and validated a new Bosch fully isolated and automated drug product vial filling line and is ready for clinical projects.
HJB congratulates its partner for receiving IND approval from FDA.